Explore how decentralized clinical trials are transforming research in Europe with Ergomed’s Regulatory Dashboard.
This whitepaper delves into the EMA’s recent recommendations on decentralization, covering key insights on digital health technology, patient engagement, and regulatory compliance. Learn how telemedicine, home-based interventions, and wearable technology are making trials more accessible and representative, while reducing participant burden and dropout rates.
Author
Marcelina Rybianska
Regulatory Affairs Director, Strategy